| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 04/29/2010 | US20100104541 Method for Preventing and Treating Cardiovascular Diseases with BRCA1 |
| 04/29/2010 | US20100104540 Methods and compositions for treatment of fibrosis |
| 04/29/2010 | US20100104539 Placental tissue grafts and improved methods of preparing and using the same |
| 04/29/2010 | US20100104537 Methods of treating Parkinson's disease using viral vectors |
| 04/29/2010 | US20100104535 Drug delivery; sustained, high-level expression of a delivered nucleotide sequence encoding erythropoietin, and for in vivo secretion thereof from transduced muscle cells such that systemic delivery |
| 04/29/2010 | US20100104534 Hydrazido-peptides as inhibitors of hcv ns3-protease |
| 04/29/2010 | US20100104533 Early intervention of viral infection with immune activators |
| 04/29/2010 | US20100104532 Nucleoside analogs for antiviral treatment |
| 04/29/2010 | US20100104531 Homogeneous preparations of il-28 and il-29 |
| 04/29/2010 | US20100104530 Anti-vpac1 antibodies and their uses |
| 04/29/2010 | US20100104529 TNF-alpha VACCINE FOR TREATING DISEASE CONDITIONS MEDIATED BY PATHOLOGICAL TNF-alpha |
| 04/29/2010 | US20100104522 Compostion for skin external use containing omega-3 fatty acid |
| 04/29/2010 | US20100104521 Cosmetic and/or pharmaceutical composition comprising as an active principle at least one peptide and use of this peptide |
| 04/29/2010 | US20100104516 Use of flagellin to prevent and treat gram negative bacterial infection |
| 04/29/2010 | US20100104507 Use of sterically stabilized cationic liposomes to efficiently deliver cpg oligonucleotides in vivo |
| 04/29/2010 | US20100104506 Nanoparticle-Coated Medical Devices And Formulations For Treating Vascular Disease |
| 04/29/2010 | US20100104503 Modular nanoparticles for adaptable vaccines |
| 04/29/2010 | DE102008053284A1 Stabilizer, useful for stabilizing heparin-binding growth factors and for manufacturing medicament e.g. for wound healing and bone regeneration, comprises a compound having an oligophosphate group |
| 04/29/2010 | DE102008053114A1 Pharmazeutischer Keratinschwamm Pharmaceutical Keratinschwamm |
| 04/29/2010 | DE102008053048A1 Medicament, useful e.g. for treating diabetes, controlling fasting, postprandial or postabsorptive blood glucose concentration in diabetic patients and improving glucose tolerance, comprises insulin and glucagon-like peptide-1 agonist |
| 04/29/2010 | CA2778170A1 Fish-derived protein lysate, and uses thereof as immunomodulatory and/or anti-inflammatory agent |
| 04/29/2010 | CA2742047A1 Compositions and methods for promoting bone formation |
| 04/29/2010 | CA2741700A1 Stable, water-insoluble r-(+)-.alpha.-lipoic acid salt useful for the treatment of diabetes mellitus and its co-morbidities |
| 04/29/2010 | CA2741548A1 Methods for determining the bioactivity of tgf-.beta. in a composition |
| 04/29/2010 | CA2741312A1 Combination therapy with peptide epoxyketones |
| 04/29/2010 | CA2741265A1 Cancer therapy |
| 04/29/2010 | CA2741130A1 Cancer treatments with radiation and immunocytokines |
| 04/29/2010 | CA2741098A1 Peptide derivatives and use thereof as carriers for molecules in the form of conjugates |
| 04/29/2010 | CA2741089A1 Modulation of axon degeneration |
| 04/29/2010 | CA2740919A1 Lyophilized recombinant vwf formulations |
| 04/29/2010 | CA2740855A1 Nutritional composition with anti-regurgitation properties |
| 04/29/2010 | CA2740299A1 Nutritional composition to promote healthy development and growth |
| 04/28/2010 | EP2180054A1 Methods and compositions for prolonging elimination half-times of bioactive compounds |
| 04/28/2010 | EP2180053A2 Wisp polypeptides and therapeutical applications thereof |
| 04/28/2010 | EP2180049A1 Devices and compositions for lysis of occlusive blood clots while sparing wound sealing clots comprising a mutant pro-urokinase |
| 04/28/2010 | EP2180044A1 Antibody glycosylation variants having increased anti-body-dependent cellular cytotoxicity |
| 04/28/2010 | EP2180007A2 Glycosylation engineering of antibodies for improving antibody-dependent cellular cytotoxicity |
| 04/28/2010 | EP2179743A1 Method for accelerating the development of suckling piglets |
| 04/28/2010 | EP2179742A1 Compositions and methods for the treatment of immune related diseases |
| 04/28/2010 | EP2179741A1 Methods for treatment of headaches by administraton of oxytocin |
| 04/28/2010 | EP2179740A1 Anti-hypertensive agent |
| 04/28/2010 | EP2179730A1 Pharmaceuticals and methods for treating hypoxia and screening methods therefor |
| 04/28/2010 | EP2179052A2 Detection of micro-organisms based on their nad-dependent dna ligase activity |
| 04/28/2010 | EP2179033A1 Methods for promoting stem cell proliferation and survival |
| 04/28/2010 | EP2179032A1 Method for preparing cells for engraftment |
| 04/28/2010 | EP2179028A1 A novel strain of bifidobacterium and active peptides against rotavirus infections |
| 04/28/2010 | EP2178936A1 Polymer compositions for biomedical and material applications |
| 04/28/2010 | EP2178912A1 Insulin analogues with an acyl and aklylene glycol moiety |
| 04/28/2010 | EP2178909A1 Rapid acting insulin analogues |
| 04/28/2010 | EP2178904A1 Psm peptides as vaccine targets against methicillin-resistant staphylococcus aureus |
| 04/28/2010 | EP2178903A2 Optimized dengue virus entry inhibitory peptide (dn81) |
| 04/28/2010 | EP2178902A1 Macrocyclic compounds as antiviral agents |
| 04/28/2010 | EP2178888A1 Proteasome inhibitors |
| 04/28/2010 | EP2178565A1 Complexes between an amphiphilic polymer and an osteogenic protein of the bmps family |
| 04/28/2010 | EP2178557A1 Composition of tumour-associated peptides and related anti-cancer vaccine |
| 04/28/2010 | EP2178556A2 Protein c for use in maintaining hemostasis |
| 04/28/2010 | EP2178555A1 Albumin for treating cancer and a pharmaceutical composition comprising the combination of an anti-neoplastic agent and albumin |
| 04/28/2010 | EP2178553A1 Use of a granulin or a granulin-like compound in the therapy or prophylaxis of chronic pains |
| 04/28/2010 | EP2178552A1 The use of type-b lantibiotic-based compounds having antimicrobial activity |
| 04/28/2010 | EP2178551A1 Novel peptides with anti-tumor activity |
| 04/28/2010 | EP2178550A2 Methods and compositions for stimulating the proliferation or differentiation of stem cells with substance p or an analog thereof |
| 04/28/2010 | EP2178549A1 Antimicrobial peptide, compositions , and methods of use |
| 04/28/2010 | EP2178548A1 Survivin peptides as cancer vaccines |
| 04/28/2010 | EP2178547A1 Pharmaceutical polypeptide dry powder aerosol formulation and method of preparation |
| 04/28/2010 | EP2178505A1 Compositions and methods for wound healing |
| 04/28/2010 | EP1730179B1 Novel mannose-specific adhesins and their use |
| 04/28/2010 | EP1673450B1 Vitamin k epoxide recycling polypeptide vkorc1, a therapeutic target of coumarin and their derivatives |
| 04/28/2010 | EP1664332B1 Kinase and phosphatase assays |
| 04/28/2010 | EP1635859B1 Therapeutic use of pam |
| 04/28/2010 | EP1581615B1 Peptide conjugated anti-cancer prodrugs |
| 04/28/2010 | EP1546362B1 Apolipoprotein e stable folding intermediate and methods of use thereof |
| 04/28/2010 | EP1539960B1 Protease-resistant modified interferon alpha polypeptides |
| 04/28/2010 | EP1487854B1 Novel isoform of vascular endothelial cell growth inhibitor (vegi) |
| 04/28/2010 | EP1347751B1 Methods of treating bone cancer and the pain associated therewith using endothelin antagonists |
| 04/28/2010 | EP1261368B1 Crosslinked, non-fungal lipase-containing composition and methods of use thereof |
| 04/28/2010 | EP1259606B1 Compositions useful for regulating parkin gene activity |
| 04/28/2010 | EP1062240B1 N-terminally modified glp-1 derivatives |
| 04/28/2010 | EP1060191B1 Derivatives of glp-1 analogs |
| 04/28/2010 | EP1056775B1 Glp-1 derivatives of glp-1 and exendin with protracted profile of action |
| 04/28/2010 | CN1972957B Potassium channel regulating pepetide |
| 04/28/2010 | CN1904041B Human recombination phospholipase D2, its preparation method and application in preparation medicine |
| 04/28/2010 | CN1901924B Method for inhibiting bacterial colonisation |
| 04/28/2010 | CN1845748B Pharmaceutical use of fish protein hydrolyzate |
| 04/28/2010 | CN1837239B Polypeptide growth factor copolymer and its preparation method and use |
| 04/28/2010 | CN1809586B Biologically active peptide comprising tyrosyl-seryl-valine (YSV) |
| 04/28/2010 | CN1809376B Liquid stabilized protein formulations in coated pharmaceutical containers |
| 04/28/2010 | CN1796403B Polypeptide and bacterin for preventing and curing infection of polytype human being papilomavirus |
| 04/28/2010 | CN1777673B Treatment of IgA1 deposition diseases |
| 04/28/2010 | CN1767848B Survivin-derived peptides and use thereof |
| 04/28/2010 | CN1761686B Proteoglycan isolated from cartilaginous fish and process for producing the same |
| 04/28/2010 | CN1756559B Stabilized aqueous compositions comprising tissue factor pathway inhibitor (TFPI) or tissue factor pathway inhibitor variant |
| 04/28/2010 | CN1731934B Ace inhibitory peptides from plant materials |
| 04/28/2010 | CN1726393B Compounds and methods for detection of carcinomas and their precursor lesions |
| 04/28/2010 | CN1688600B Template-fixed peptidomimetics with antibacterial activity |
| 04/28/2010 | CN1668290B Modified amino acid for the inhibition of platelet aggregation |
| 04/28/2010 | CN1662260B Process for producing sustained-release composition |
| 04/28/2010 | CN1658855B O-substituted hydroxyaryl derivatives |
| 04/28/2010 | CN1652698B Method and dietary composition for improving lipid digestibility |
| 04/28/2010 | CN1652697B Method and dietary composition for improving fat digestibility |
| 04/28/2010 | CN1652696B Method of improving absorption of vitamin E by a pet animal |